Table I.
Associations between miR-495 expression and the clinicopathological characteristics of patients with non-small cell lung cancer.
| miR-495 [n (%)] | ||||
|---|---|---|---|---|
| Clinicopathological features | n | Low expression | High expression | P-value |
| Gender | 0.316 | |||
| Male | 80 | 40 (50.00) | 40 (50.00) | |
| Female | 42 | 25 (59.52) | 17 (40.48) | |
| Age (year) | 0.179 | |||
| >60 | 72 | 42 (58.33) | 30 (41.67) | |
| ≤60 | 50 | 23 (46.00) | 27 (54.00) | |
| Tumor size | 0.312 | |||
| >5 cm | 53 | 31 (58.49) | 22 (41.51) | |
| ≤5 cm | 69 | 34 (49.28) | 35 (50.72) | |
| Tumor differentiation | 0.008a | |||
| Well + Moderate | 77 | 34 (44.16) | 43 (55.84) | |
| Poorly | 45 | 31 (68.89) | 14 (31.11) | |
| TNM stage | 0.024a | |||
| I + II | 84 | 39 (46.43) | 45 (53.57) | |
| III | 38 | 26 (68.42) | 12 (31.58) | |
| Smoking | 0.298 | |||
| Yes | 51 | 30 (58.82) | 21 (41.18) | |
| No | 71 | 35 (49.30) | 36 (50.70) | |
| Lymphatic metastasis | 0.005a | |||
| Yes | 72 | 46 (63.89) | 26 (36.11) | |
| No | 50 | 19 (38.00) | 31 (62.00) | |
| Pathology classification | 0.081 | |||
| Squamous cell carcinoma | 54 | 24 (44.44) | 30 (55.56) | |
| Adenocarcinoma | 68 | 41 (60.29) | 27 (39.71) | |
a
P<0.05. miR, microRNA; TNM, tumor, node and metastasis.